American Journal of Transplantation

Papers
(The H4-Index of American Journal of Transplantation is 60. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
OPTN/SRTR 2019 Annual Data Report: Kidney296
COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium295
Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus275
OPTN/SRTR 2019 Annual Data Report: Liver250
OPTN/SRTR 2020 Annual Data Report: Liver246
First clinical-grade porcine kidney xenotransplant using a human decedent model241
OPTN/SRTR 2020 Annual Data Report: Kidney236
Decreased influenza activity during the COVID-19 pandemic—United States, Australia, Chile, and South Africa, 2020226
Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients199
Is COVID-19 infection more severe in kidney transplant recipients?192
COVID-19 in transplant recipients: The Spanish experience139
OPTN/SRTR 2019 Annual Data Report: Lung132
OPTN/SRTR 2021 Annual Data Report: Kidney126
SARS-CoV-2 infection and early mortality of waitlisted and solid organ transplant recipients in England: A national cohort study126
Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients124
OPTN/SRTR 2020 Annual Data Report: Heart122
Long-term kidney transplant graft survival—Making progress when most needed121
OPTN/SRTR 2021 Annual Data Report: Liver119
Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipients115
Donor to recipient transmission of SARS-CoV-2 by lung transplantation despite negative donor upper respiratory tract testing114
Clinical characteristics and outcomes of COVID-19 in solid organ transplant recipients: A cohort study113
Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients108
Impact of COVID-19 in solid organ transplant recipients106
Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients102
COVID-19 vaccination intent, perceptions, and reasons for not vaccinating among groups prioritized for early vaccination — United States, September and December 2020100
Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients99
Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: Outcomes and risk factors for graft loss97
OPTN/SRTR 2019 Annual Data Report: Heart95
Tixagevimab/cilgavimab pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave93
PD-1 inhibitor as bridge therapy to liver transplantation?89
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept87
Ten years of donor-derived disease: A report of the disease transmission advisory committee87
Ischemia-reperfusion injury and its relationship with early allograft dysfunction in liver transplant patients86
OPTN/SRTR 2020 Annual Data Report: Lung85
Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States85
A systematic review and meta-analysis of COVID-19 in kidney transplant recipients: Lessons to be learned84
Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients82
Clinical characteristics and risk factors for severe COVID-19 in hospitalized kidney transplant recipients: A multicentric cohort study78
Cellular and humoral immune response after mRNA-1273 SARS-CoV-2 vaccine in liver and heart transplant recipients78
Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement78
Kidney transplantation from triple-knockout pigs expressing multiple human proteins in cynomolgus macaques78
Kidney transplant patients with SARS-CoV-2 infection: The Brescia Renal COVID task force experience74
Sequential hypothermic and normothermic machine perfusion enables safe transplantation of high-risk donor livers74
Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes72
A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients71
Hypothermic oxygenated perfusion in extended criteria donor liver transplantation—A randomized clinical trial69
Use of tocilizumab in kidney transplant recipients with COVID-1968
OPTN/SRTR 2021 Annual Data Report: Lung67
Neutralization against Omicron variant in transplant recipients after three doses of mRNA vaccine66
Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID-19 in solid organ transplant recipients66
COVID-19 infection in solid organ transplant recipients after SARS-CoV-2 vaccination65
Incidence and outcome of SARS-CoV-2 infection on solid organ transplantation recipients: A nationwide population-based study64
Real-world experience with available, outpatient COVID-19 therapies in solid organ transplant recipients during the omicron surge64
Changing trends in mortality among solid organ transplant recipients hospitalized for COVID-19 during the course of the pandemic62
Early success transplanting kidneys from donors with new SARS-CoV-2 RNA positivity: A report of 10 cases62
A prospective multicenter pilot study of HIV-positive deceased donor to HIV-positive recipient kidney transplantation: HOPE in action60
COVID-19 outcomes in patients waitlisted for kidney transplantation and kidney transplant recipients60
Clinical importance of extended second field high-resolution HLA genotyping for kidney transplantation60
In-depth virological assessment of kidney transplant recipients with COVID-1960
Effectiveness of SARS-CoV-2 vaccination in fully vaccinated solid organ transplant recipients60
0.10374402999878